MARC 主機 00000cam a2200505 a 4500 
001    002229379 
005    20140523160245.0 
006    m     o  d         
007    cr cnu---unuuu 
008    161115s2013    nju     ob    001 0 eng d 
010    2012040270 
020    9781118354599 (electronic bk.) 
020    1118354591 (electronic bk.) 
020    9781118354575 (electronic bk.) 
020    1118354575 (electronic bk.) 
020    9781299241954 (MyiLibrary) 
020    1299241956 (MyiLibrary) 
020    |z9781118354582 
020    |z1118354583 
020    |z9781118354568 
020    |z1118354567 
020    |z9780470646274 (cloth) 
020    |z0470646276 (cloth) 
040    DLC|beng|cDLC|dYDX|dDG1|dN|T|dYDXCP|dE7B|dCDX|dIDEBK|dCOO
       |dNOC|dOCLCO|dOCLCF|dCCO|dAS 
041 0  eng 
050  4 RM301.4|b.F87 2013 
060 10 QU 450 
082 00 615.7|223 
245 00 Fusion protein technologies for biopharmaceuticals
       |h[electronic resource] :|bapplications and challenges /
       |cedited by Stefan R. Schmidt 
250    1st ed 
260    Hoboken, N.J. :|bJohn Wiley & Sons,|cc2013 
300    1 online resource 
504    Includes bibliographical references and index 
588    Description based on online resource; title from digital 
       title page (viewed on Jan. 9, 2014) 
588    Description based on print version record 
650  0 Biopharmaceutics 
650  0 Pharmaceutical biotechnology 
650 12 Recombinant Fusion Proteins|xtherapeutic use 
650 22 Recombinant Fusion Proteins|xpharmacokinetics 
650 22 Immunotoxins|xtherapeutic use 
650 22 Immunotoxins|xpharmacokinetics 
650 22 Drug Carriers 
650 22 Protein Engineering 
700 1  Schmidt, Stefan R 
856 40 |uhttp://onlinelibrary.wiley.com/book/10.1002/
       9781118354599|zeBook(Wiley)